These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Noradrenergic Modulation of Methamphetamine-Induced Striatal Dopamine Depletion. Fornai F; Alessandrì MG; Torrac MT; Bassi L; Scalori V; Corsini GU Ann N Y Acad Sci; 1998 May; 844(1):166-177. PubMed ID: 29090815 [TBL] [Abstract][Full Text] [Related]
10. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP. Andrews AM; Murphy DL J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744 [TBL] [Abstract][Full Text] [Related]
11. Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion. Geldenhuys WJ; Darvesh AS; Dluzen DE Neurochem Int; 2012 Jun; 60(8):806-8. PubMed ID: 22710395 [TBL] [Abstract][Full Text] [Related]
12. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Lau YS; Trobough KL; Crampton JM; Wilson JA Gen Pharmacol; 1990; 21(2):181-7. PubMed ID: 2332138 [TBL] [Abstract][Full Text] [Related]
13. Methamphetamine protects against MPTP neurotoxicity in C57BL mice. Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986 [TBL] [Abstract][Full Text] [Related]
14. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum. Chan P; Langston JW; Di Monte DA J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813 [TBL] [Abstract][Full Text] [Related]
15. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Holmer HK; Keyghobadi M; Moore C; Meshul CK Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485 [TBL] [Abstract][Full Text] [Related]
16. Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice. Kita T; Paku S; Takahashi M; Kubo K; Wagner GC; Nakashima T Neuropharmacology; 1998 Sep; 37(9):1177-84. PubMed ID: 9833648 [TBL] [Abstract][Full Text] [Related]
17. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction]. Nishi K; Kondo T; Narabayashi H No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916 [TBL] [Abstract][Full Text] [Related]
18. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP. Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028 [TBL] [Abstract][Full Text] [Related]
19. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum]. Sheng JG Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971 [TBL] [Abstract][Full Text] [Related]
20. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1). Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]